India  

Sputnik V cleared for launch in India: Five things you need to know about Russian vaccine

IndiaTimes Tuesday, 13 April 2021
Following the recommendation of the Drug Controller General of India (DGCI)'s subject expert committee, Russia's anti-Covid vaccine Sputnik V now awaits final approval from the drug regulator. Once approved, Hyderabad-based Dr Reddy's Labs will initially import the vaccine in small amounts to supply to the government.
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: Doctors welcome India's approval to 'Sputnik V' vaccine

Doctors welcome India's approval to 'Sputnik V' vaccine 01:50

Subject Expert Committee of union government on April 12 approved Dr Reddy's application for emergency use authorisation to Russian COVID vaccine 'Sputnik V' in India. With this, India has now three COVID-19 vaccines in use. Welcoming the step, Medical Superintendent of RML Hospital, Dr Rana AK Singh...

You Might Like


💡 newsR Knowledge: Other News Mentions

Sputnik V COVID-19 vaccine Sputnik V COVID-19 vaccine Vaccine against COVID-19

36 crore Indians to get Sputnik V COVID-19 vaccine jabs by March 2022

RDIF, which is the Russian sovereign wealth fund that has funded the vaccine, has signed pacts with 5 Indian companies to produce 850 million doses.
DNA

Russia's single-dose COVID-19 vaccine Sputnik Light to be produced in India

India has given approval to Sputnik V and the first consignment arrived in the country on May 1.
DNA
Russia approves Sputnik's single-shot vaccine [Video]

Russia approves Sputnik's single-shot vaccine

Russia on May 06 approved Sputnik Light, the single-dose vaccine against COVID-19. According to the information on Sputnik V's twitter handle, the single-dose vaccine has 79.4% overall efficacy against coronavirus, and is a "reliable pandemic fighter". Sputnik V, which is approved in 64 countries with a total population of over 3.2 billion people, has already started arriving in India for emergency use.

Credit: ANI    Duration: 01:08Published

Drugs Controller General of India Drugs Controller General of India

Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen [Video]

Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen

From DCGI approving new anti-Covid drug, to health ministry issues new rules for hospital admissions, here are the top updates on the coronavirus. DCGI approved a new anti-Covid oral drug, which has been developed by DRDO and Dr. Reddy’s. The medicine has been given emergency use approval by DCGI. Meanwhile, Health Ministry said that a positive Covid-19 report is now not mandatory for a patient to be admitted to a hospital. Also, Supreme Court formed a 12-member National Task Force on medical oxygen. The new panel includes 10 doctors and 2 top bureaucrats from the Centre, who will ensure streamlined delivery of oxygen across India. Watch the full video for more updates on the pandemic.

Credit: HT Digital Content    Duration: 03:24Published
DCGI approves DRDO's anti-COVID drug helpful in faster recovery [Video]

DCGI approves DRDO's anti-COVID drug helpful in faster recovery

Drugs Controller General of India (DCGI) on May 08 approved emergency use DRDO's anti-COVID drug which the agency said will be helpful in faster recovery of hospitalised patients. While speaking to ANI, Institute of Nuclear Medicine and Allied Sciences (INMAS-DRDO) scientists spoken about drug 2-deoxy-D-glucose (2-DG). The drug will be of immense benefit to the people suffering from COVID-19.

Credit: ANI    Duration: 02:44Published
What is 2-DG: New drug approved for Covid emergency use | Oneindia News [Video]

What is 2-DG: New drug approved for Covid emergency use | Oneindia News

The Drugs Controller General of India has granted permission for emergency use of therapeutic application of drug 2-deoxy-D-glucose or 2-DG as adjunct therapy. This was used to treat cancer and showed efficacy in Covid treatment. #Covid #2DG #EmergencyUse

Credit: Oneindia    Duration: 01:24Published

Potential cancer drug repurposed for Covid-19 by DRDO, Dr Reddy's gets DCGI nod for emergency use

A potential cancer drug repurposed for Covid-19 treatment -- 2-deoxy-D-glucose (2-DG) – has received the Drugs Controller General of India (DCGI) nod for..
IndiaTimes

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

WHO warns against use of Ivermectin to treat Covid-19

A day after Goa's health minister Vishwajit Rane recommended Ivermectin to all above 18 to combat Covid in the state, the World Health Organisation on Tuesday..
IndiaTimes

PM Modi speaks with Lotay Tshering; thanks Bhutan for support in wake of Covid pandemic

PM Narendra Modi held a telephonic conversation with his Bhutanese counterpart Lotay Tshering on Tuesday as the two leaders noted that the coronavirus crisis has..
IndiaTimes
Blake Shelton joins initiative to provide meals to out-of-work musicians [Video]

Blake Shelton joins initiative to provide meals to out-of-work musicians

The COVID-19 pandemic has drastically affected the live music industry.

Credit: Cover Video STUDIO    Duration: 01:13Published

Dr. Reddy's Laboratories Indian multinational pharmaceutical company

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials [Video]

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials

Institute of Nuclear Medicine and Allied Sciences-DRDO scientist Dr Sudhir Chandna on drug 2-deoxy-D-glucose (2-DG) while speaking to ANI informed about the observations of the medicine's clinical trials. "110 patients in ph 2 and 220 patients in ph 3 participated in clinical trials. It has shown better efficacy in ph 2. Recovery was 2-3 days faster for COVID patients. Phase 3 data shows by day 3, freedom from oxygen dependence seen in 42% patients as compared to 31% patients who were in standard care," said Dr Sudhir Chandna. Further referring to the data obtained he said that oxygen dependence reduced in a better way when we use this medicine along with standard care. "The pricing will depend on the production and those factors are with Dr. Reddy's Laboratories who are our industry partners," said DRDO scientist. On medicine's roll out, he said that it might come out in few days.

Credit: ANI    Duration: 01:59Published
Sputnik V is stored at -18C: Dr Reddy's Lab Global Logistics' Head [Video]

Sputnik V is stored at -18C: Dr Reddy's Lab Global Logistics' Head

Sputnik V is a minus 18-degrees Celsius storage vaccine, informed Ravi Mathur, Global Logistics' Head, Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01."Sputnik V is a minus 18-degrees Celsius storage vaccine. We have created a state-of-the-art central warehouse that operates below minus 20-degrees Celsius. These are single-dose ampules, once taken out have to be administered within 30 mins," informed Head of global logistics at Dr. Reddy's lab.

Credit: ANI    Duration: 01:43Published
Sputnik V will be available in few weeks after statutory clearances: Dr Reddy's Lab CEO [Video]

Sputnik V will be available in few weeks after statutory clearances: Dr Reddy's Lab CEO

The Sputnik V vaccine will be available in a few weeks after statutory clearances, informed Deepak Sapra, CEO of Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01. "Today, we have received 1,50,000 doses of Sputnik V vaccine here in Hyderabad. The vaccine will be available in a few weeks after it has gone through statutory clearances. The price will also be announced then," said CEO Sapra.

Credit: ANI    Duration: 01:02Published
150,000 doses of Sputnik V have arrived in India on 1st May | Oneindia News [Video]

150,000 doses of Sputnik V have arrived in India on 1st May | Oneindia News

Sputnik V is the Russian made covid vaccine with an efficacy rate above 90%. 150,000 doses of Sputnik have arrived at Hyderabad in India on Saturday. The vaccines will be handed over to Dr Reddy's Laboratories, and soon to be distributed among the healthcare systems of the country. #covid19 #covid vaccines #SputnikV #Russia #Indiacovidcrisis

Credit: Oneindia    Duration: 01:01Published

Hyderabad Hyderabad Capital of Telangana, India

Hyderabad's Calvary Temple turns into 300-bed COVID care centre [Video]

Hyderabad's Calvary Temple turns into 300-bed COVID care centre

With upsurge in country's COVID-19 cases, many organisations have come forward to offer their best during these tough times. Telangana's Calvary Temple has been converted into a COVID care centre. The 300-bed capacity centre was inaugurated by TRS leader and MLC K Kavitha. It is a highly equipped centre with oxygen support and has round the clock presence of doctors and nurses. The temple association is looking forward to further increase the bed capacity to 1,000 in coming days.

Credit: ANI    Duration: 01:50Published
Watch: Portable oxygen generator made by Hyderabad start-up amid Covid crisis [Video]

Watch: Portable oxygen generator made by Hyderabad start-up amid Covid crisis

A Hyderabad-based start-up claims to have developed a portable and affordable oxygen generator. India is currently facing an acute shortage of medical oxygen amid a huge rise in Covid-19 cases. The Phi Factory co-founder Praveen Gorakavi said that the machine can support two patients for six hours, or one for twelve hours. It can prove to be crucial in saving lives while patients await medical care. Watch the full video for more.

Credit: HT Digital Content    Duration: 02:45Published
COVID: Hyderabad start-up invents affordable oxygenator to address oxygen crisis [Video]

COVID: Hyderabad start-up invents affordable oxygenator to address oxygen crisis

As the country is reeling under the horrific second wave of pandemic and acute oxygen shortage, a start-up in Hyderabad came up with a invention to address the crisis. 'The Phi Factory' has created a portable oxygenerator, which works on Hydrogen Peroxide, under the name 'Project Vayuputra'. Vayuputra has been developed with an objective to support COVID-19 patients who are under home isolation. Price of this oxygenerator would be around Rs. 2,500 to Rs. 2,600 that includes the oxygenerator along with 10x2 liter bottles of Hydrogen Peroxide.

Credit: ANI    Duration: 02:40Published

Related videos from verified sources

Russia's single-shot vaccine Sputnik Light gets the nod for use | Set to be produced in India [Video]

Russia's single-shot vaccine Sputnik Light gets the nod for use | Set to be produced in India

Sputnik Light is the single-shot version of Sputnik V. Its developers include Russia's health ministry, Gamaleya Research Center of Epidemiology and Microbiology, and the RDIF. On Thursday, they said..

Credit: Oneindia     Duration: 01:01Published
Vaccine production is truly international collaboration in India: EAM [Video]

Vaccine production is truly international collaboration in India: EAM

Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05. He said, "Our vaccine production situation was different from many other..

Credit: ANI     Duration: 01:57Published
Vaccine single dose: Is it efficient? Studies say this...| Oneindia News [Video]

Vaccine single dose: Is it efficient? Studies say this...| Oneindia News

While it must be understood that taking both doses of any vaccine whether it be Covishield, Covaxin or Sputnik, the ones that are available in India, are critical, here is what we know about one dose..

Credit: Oneindia     Duration: 01:30Published

Related news from verified sources

3 ways to find the nearest COVID-19 vaccination centre amid rising COVID-19 cases in India

COVID-19 cases are rising at an alarming rate in India. Due to the sudden increase in cases, several state governments have announced partial lockdown and have...
BGR India

Microsoft CEO Satya Nadella supports India fighting COVID-19, says “I am heartbroken”

Microsoft’s Satya Nedalla is heartbroken with what India is going through right now. The COVID-19 second wave has hit the country and how. India is currently...
BGR India Also reported by •IndiaTimesZee News

COVID-19 second wave: Amazon announces delivery of only essential products in India

COVID-19 second wave has hit India and how. Coronavirus cases are rising at a massive scale in the country. Amid the rising cases of COVID-19 across the country,...
BGR India